Vaccine Science Briefing

The MHRA has recommended the approval of the Pfizer-BioNTech COVID-19 vaccine to the UK Government, following a thorough review of its safety, effectiveness, and quality. The UK Government has accepted this advice, approving the vaccine for adults aged 16 and over with certain conditions. The development process was expedited by overlapping clinical trials, and the MHRA used a rolling review to ensure a comprehensive assessment without cutting corners.

What new insight or understanding did you gain from this video?